Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional paid in capital
Retained earnings
Accumulated other comprehensive (loss)/income
Non- controlling interest
Shares issued, beginning of period (in shares) at Mar. 31, 2021   58,443,212,000        
Equity, beginning of period at Mar. 31, 2021 $ 307,671 $ 58 $ 135,260 $ 214,427 $ (40,433) $ (1,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation 6,723 $ 1 6,722      
Stock based compensation (in shares)   1,031,500,000        
Sale of Freedom Finance Ukraine LLC shares 416   (796)     1,212
Contribution of shareholder 1,966   1,966      
Exercise of options (in shares)   60,000,000        
Exercise of options 119   119   0  
Other comprehensive income (74)       (74)  
Translation difference 4,203       4,203  
Net income 262,111     262,183   (72)
Shares issued, end of period (in shares) at Sep. 30, 2021   59,534,712,000        
Equity, end of period at Sep. 30, 2021 583,135 $ 59 143,271 476,610 (36,304) (501)
Shares issued, beginning of period (in shares) at Jun. 30, 2021   59,474,712,000        
Equity, beginning of period at Jun. 30, 2021 370,395 $ 58 138,687 269,849 (36,506) (1,693)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation 4,562 $ 1 4,561      
Sale of Freedom Finance Ukraine LLC shares 416   (796)     1,212
Contribution of shareholder 700   700      
Exercise of options (in shares)   60,000,000        
Exercise of options 119   119   0  
Other comprehensive income (979)       (979)  
Translation difference 1,181       1,181  
Net income 206,741     206,761   (20)
Shares issued, end of period (in shares) at Sep. 30, 2021   59,534,712,000        
Equity, end of period at Sep. 30, 2021 583,135 $ 59 143,271 476,610 (36,304) (501)
Shares issued, beginning of period (in shares) at Mar. 31, 2022   59,542,212        
Equity, beginning of period at Mar. 31, 2022 546,608 [1] $ 59 174,745 441,924 (63,125) (6,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation 6,801   6,801      
Contribution of shareholder 677   677      
Acquisition of insurance companies (26,588)   (26,588)      
Other comprehensive income 2,234       2,234  
Translation difference 5,316       5,316  
Net income 86,283     87,327   (1,044)
Shares issued, end of period (in shares) at Sep. 30, 2022   59,542,212        
Equity, end of period at Sep. 30, 2022 621,331 $ 59 155,635 529,251 (55,575) (8,039)
Shares issued, beginning of period (in shares) at Jun. 30, 2022   59,542,212        
Equity, beginning of period at Jun. 30, 2022 606,918 $ 59 152,532 502,989 (39,673) (8,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation 3,103   3,103      
Contribution of shareholder     0      
Other comprehensive income 761       761  
Translation difference (16,663)       (16,663)  
Net income 27,212     26,262   950
Shares issued, end of period (in shares) at Sep. 30, 2022   59,542,212        
Equity, end of period at Sep. 30, 2022 $ 621,331 $ 59 $ 155,635 $ 529,251 $ (55,575) $ (8,039)
[1] * Please see Note 3